All Episodes
The Lancet Neurology in conversation with — 68 episodes
Henry Brodaty and Alice Powell on cognitive resilience and ageing
Niklas Mattsson-Carlgren on the use of biomarkers in the diagnosis and stratification of Alzheimer’s disease
Cristina Tassorelli on migraine prevention
Inga Zerr and Simon Mead on advances in prion diseases
Julia Greenland on azathioprine for early Parkinson’s disease
Ian McKeith on dementia with dementia with Lewy bodies
Ask Nordestgaard on long-term stroke risk in women
Shiv Saidha on recent updates in the diagnosis of multiple sclerosis
Michael Rafii on Down syndrome-related Alzheimer’s disease
Amit Bar-Or on fenebrutinib for relapsing multiple sclerosis
Marte-Helene Bjørk on reproductive risks in people with epilepsy
Geoff Manley on a new classification system for traumatic brain injury
Wayne Feng on stroke rehabilitation using brain stimulation and constraint-induced movement therapy
Marialuisa Gandolfi on the management of chronic pain in Parkinson’s disease
Michael Tymianski on neuroprotection in stroke
Elizabeth Finger on oxytocin for apathy in frontotemporal dementia
The Lancet Neurology Editors on advances in neurology in 2024
Florian Krismer and Elizabeth Coon on multiple system atrophy
Suvankar Pal on the motor neuron disease trial MND-SMART
Jorge Correale and Lilyana Amezcua on differential diagnosis of multiple sclerosis
Alex Iranzo on sleep and Parkinson’s disease
Adrian Owen on detecting awareness after acute brain injury
Glenn Nielsen on specialist physiotherapy for people with functional motor disorder
Sanjay Sisodiya on climate change and brain health
Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy
Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system
Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders
Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy
Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury
Rustam Al-Shahi Salman on the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage
Njideka Okubadejo and Mie Rizig on Parkinson’s disease in African and African admixed populations
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis
William Jagust on amyloid β and cognition
Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury
Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases
Andrew Cole on the complexities underlying epilepsy in people with glioblastoma
Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation
Kerstin Hellwig on family planning considerations in MS
Geraldine Dawson on advances in the prediction of autism during infancy
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke
Beau Ances on amyloid biomarkers in Alzheimer’s
Axel Petzold on the diagnosis and classification of optic neuritis
Maeike Zijlmans on using biomarkers to tailor epilepsy surgery
Jerome Siegel on sleep habits
Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy
Sarah Tabrizi and Cristina Sampaio on classifying Huntington’s and new therapies
Mark Hallett on functional neurological disorder
Eva Feldman on advances in understanding ALS
Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer’s
John Collinge on a treatment for CJD
Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2
Giuseppe Citerio on frailty and TBI
Alberto Costa on memantine in adolescents and young adults with Down syndrome
Olivier Rascol on amantadine for patients with movement disorders
Antonio Uccelli on stems cells for MS
Priya Palta on blood pressure control and cognitive decline
Adam Boxer on tau biomarkers
Irene Cortese on the difficulties of designing clinical trials
Doug Turnbull on mitochondrial diseases in adults
Geert Jan Biessels on predicting post-stroke cognitive impairment
Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS
Anne MacGregor on menstrual migraine
Peter Rothwell on asymptomatic carotid stenosis and stroke
Spinal cord injury and degenerative cervical myelopathy
Genetic risk factors for sCJD
Prednisone in short-term prevention of cluster headache
PET imaging of inflammation in neurological and psychiatric disorders